Analysis of 117 Cases of Adverse Drug Reactions Induced by Bevacizumab Injection

WANG Mingmei; MA Jianli; WANG Xinhui; WEI Jinfei; LI Sha; XU Yulian

doi:10.14009/j.issn.1672-2124.2020.07.026

您当前的位置：

首页 >

文章列表页 >

Analysis of 117 Cases of Adverse Drug Reactions Induced by Bevacizumab Injection

更新时间：2022-10-08

- Analysis of 117 Cases of Adverse Drug Reactions Induced by Bevacizumab Injection
- Vol. 20, Issue 7, Pages: 872-875(2020)
- 作者机构：
  
  解放军总医院第四医学中心药剂药理科
- 作者简介：
- 基金信息：
- DOI：10.14009/j.issn.1672-2124.2020.07.026
  CLC： R979.1
- Published：2020，
扫描看全文
[1]王明媚,马建丽,王心慧,卫晋菲,李莎,许玉莲.117例贝伐珠单抗注射液致药品不良反应的特点分析[J].中国医院用药评价与分析,2020,20(07):872-875.

WANG Mingmei, MA Jianli, WANG Xinhui, et al. Analysis of 117 Cases of Adverse Drug Reactions Induced by Bevacizumab Injection. [J]. 20(7):872-875(2020)
[1]王明媚,马建丽,王心慧,卫晋菲,李莎,许玉莲.117例贝伐珠单抗注射液致药品不良反应的特点分析[J].中国医院用药评价与分析,2020,20(07):872-875. DOI： 10.14009/j.issn.1672-2124.2020.07.026.

WANG Mingmei, MA Jianli, WANG Xinhui, et al. Analysis of 117 Cases of Adverse Drug Reactions Induced by Bevacizumab Injection. [J]. 20(7):872-875(2020) DOI： 10.14009/j.issn.1672-2124.2020.07.026.

摘要

目的:探讨贝伐珠单抗注射液致药品不良反应（adverse drug reaction

ADR）的规律和特点

为合理用药提供依据。方法:收集2016年9月至2019年12月解放军总医院第四医学中心使用贝伐珠单抗注射液的病例

共纳入符合入选标准的患者117例

其中男性患者65例

女性患者52例

调取其入院记录

归纳分析发生ADR患者的原患疾病、性别、年龄以及ADR严重程度分级。结果:117例使用贝伐珠单抗注射液的患者中

发生贝伐珠单抗注射液药品说明书中提及的ADR共75例

排除合并用药因素

与贝伐珠单抗注射液高度相关的ADR有39例。贝伐珠单抗注射液主要的ADR分别为高血压（18例

发生率为15.38%）、胃肠道不适（15例

发生率为12.82%）、过敏（7例

发生率为5.98%）、出血（6例

发生率为5.13%）和蛋白尿（2例

发生率为1.71%）

未发生致死性ADR。结论:贝伐珠单抗注射液所致ADR较轻微

但临床应用时应熟悉其致ADR的特点

排除使用该药可能发生严重ADR的高危人群

并对其常见的ADR进行密切监测

做到及时、有效处理。

Abstract

OBJECTIVE: To investigate the laws and characteristics of adverse drug reactions（ ADR） induced by bevacizumab injection

and to provide evidence for rational drug use.METHODS: Patients treated with bevacizumab were collected from the Fourth Medical Center of PLA General Hospital from Sept.2016 to Dec.2019.A total of 117 patients who met the inclusion criteria were enrolled

including 65 male patients and 52 female patients.The admission records were collected to summarize and analyze the primary disease

gender

age and severity grade of ADR.RESULTS: Of the 117 patients received bevacizumab injection

75 cases had ADR mentioned in the instructions for bevacizumab injection

and 39 cases had ADR that was highly correlated with bevacizumab injection

excluding the combination of drug factors.The main ADR of bevacizumab injection were hypertension（ 18 cases

the incidence rate was 15.38%）

gastrointestinal discomfort（ 15 cases

the incidence rate was 12.82%）

allergy（ 7 cases

the incidence rate was 5.98%）

hemorrhage（ 6 cases

the incidence rate was 5.13%） and proteinuria（ 2 cases

the incidence rate was 1.71%）.No fatal adverse drug reactions occured.CONCLUSIONS: ADR induced by bevacizumab injection is relatively mild

yet the characteristics of ADR induced by bevacizumab injection should be understand in clinical application

so as to exclude the high-risk population that may have severe ADR induced by bevacizumab injection

and the common ADR should be closely monitored to ensure timely and effective treatment.

关键词

贝伐珠单抗药品不良反应合理用药

Keywords

BevacizumabAdverse drug reactionsRational drug use

references

查看原文

Views

161

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Reports of 799 Cases of Adverse Drug Reactions Induced by Iohexol in Beijing from 2016 to 2020

Adverse Drug Reactions Induced by Linezolid in 84 Patients with Drug-Resistant Tuberculosis

Analysis and Discussion of 858 Cases of Adverse Drug Reactions Induced by Contrast Mediums

Application Rationality of Ticagrelor in 162 Cases of Elderly Patients with Coronary Heart Disease

Analysis of Literature on Case Reports of Adverse Drug Reactions Induced by Montelukast Sodium in Children

Related Author

XIE Yue

ZHANG Chao

CHENG Kai

LI Na

CHEN Xiaoyou

MU Xiaopan

GUO Zhenyong

WANG Ying

Related Institution

Dept. of Pharmacy, Beijing Tongren Hospital, Capital Medical University

Medical Office, Beijing Ditan Hospital, Capital Medical University

Dept. of Pharmacy, Beijing Friendship Hospital, Capital Medical University

Dept.of Pharmacy, Beijing Tuberculosis and Thoracic Tumor Research Institute/Beijing Chest Hospital, Capital Medical University

Dept. of Pharmacy,Fuwai Hospital,Chinese Academy of Medical Sciences

⁰